Sign in
VBIO Stock Price, Chart, Stats & News
Malachite Innovations, Inc.
Save
Malachite Innovations, Inc. (VBIO) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
VBIO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -98.22% |
ROE | -82.10% |
D/E | – |
Interest coverage ratio | – |
VBIO valuation
P/E | – |
P/S | – |
P/B | 22.96x |
P/CF | -12.35x |
P/FCF | – |
P/OCF | -12.35x |
PEG | -0.23x |
EV multiple | -1.00x |
About
Vitality Biopharma, Inc. specializes in creating cannabinoid-based pharmaceuticals, primarily focusing on addressing inflammatory disorders within the United States. Its current pipeline includes tetrahydrocannabinol glycoside, identified as VBX-100, an orally administered cannabinoid prodrug engineered to combat inflammatory bowel disease (IBD) and irritable bowel syndromes (IBS). Established in 2007, the company originally operated as Stevia First Corp. before officially rebranding as Vitality Biopharma, Inc. in July 2016.
Similar securities
Based on sector and market capitalization
Report issue